- The genomic landscape associated with resistance to aromatase inhibitors in breast cancer
-
Sadasivam K, Manoharan JP, Palanisamy H, Vidyalakshmi S
- KMID: 2543699
- Genomics Inform.
- 2023 Jun;21(2):e20.
- doi: 10.5808/gi.23012
Aromatase inhibitors (AI) are drugs that are widely used in treating estrogen receptor (ER)–positive breast cancer patients. Drug resistance is a major obstacle to aromatase inhibition therapy. There are diverse... -
- CITED
-
- Close
- SHARE
-
- Close
